BioSpace News Archive

FDA

Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

Hologic Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Panther Fusion® SARS-CoV-2/Flu A/B/RSV assay.

May 19, 2023
·
4 min read
Drug Development

Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced multiple clinical and preclinical updates from its portfolio of investigational hematopoietic stem cell (HSC) gene therapies in neurometabolic and neurodegenerative disorders.

May 19, 2023
·
16 min read
Biotech Beach

Cytek Biosciences Announces $50 Million Stock Repurchase Program

Cytek Biosciences, Inc., a leading cell analysis solutions company, announced that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law.

May 19, 2023
·
5 min read
Biotech Bay

Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity While Achieving Precise Brain Expression in Non-Human Primates, Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting

Encoded Therapeutics announced today the presentation of non-human primate (NHP) validation of the company’s technology to drive desired gene and protein expression patterns at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting.

May 19, 2023
·
2 min read
Biotech Bay

Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia

Varian, a Siemens Healthineers company, announced today that the first participant has been treated in the RADIATE-VT™ clinical trial (NCT 05765175) at Washington University School of Medicine in St. Louis, MO.

May 19, 2023
·
4 min read
American Aires Inc. Announces Filing of Q1/2023 Financial Statements and MD and A

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a leader in scientifically-proven EMF modulation technology, is pleased to announce the filing of its unaudited Financial Statements and the MD&A for the first quarter of 2023, covering the period January 1 to March 31, 2023

May 19, 2023
·
5 min read
Biotech Beach

Adamis Pharmaceuticals Announces Reverse Stock Split - May 19, 2023

Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, announced that it will effect a 1-for-70 reverse stock split of its common stock that will become effective on May 22, 2023, at 12:01 a.m., Eastern Time.

May 19, 2023
·
6 min read
Genetown

Aquyre Biosciences wins top award from French American Chamber of Commerce, New England

Aquyre Biosciences, Inc. the creator of CelTivity, the industry leader in two-minute lung biopsy adequacy assessment, announced that Aquyre Biosciences and its founder Bertrand De Poly have been recognized with the 2023 FAB Life Sciences Award, from the French American Chamber of Commerce, New England.

May 19, 2023
·
2 min read
Pharm Country

KaliVir Immunotherapeutics Announces New In Vivo Data Demonstrating Superior Therapeutic Efficacy of VET3-TGI at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

KaliVir Immunotherapeutics, Inc. announced the presentation of new data on its lead pre-clinical candidate VET3-TGI at the American Society of Gene & Cell Therapy 26th Annual Meeting.

May 19, 2023
·
3 min read
Genetown

Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation at ASGCT 2023

Chroma Medicine, Inc., a genomic medicine company pioneering single-dose epigenetic editing therapeutics, presented data demonstrating the advantages of epigenetic editing for multiplex gene regulation at the American Society of Gene & Cell Therapy 26th Annual Meeting in Los Angeles.

May 19, 2023
·
3 min read